Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades.
Nutritional oncology is an increasingly active interdisciplinary field where cancer is investigated as both a systemic and local disease originating with the changes in the genome and progressing through a multi-step process which may be influenced at many points in its natural history by nutritional factors that could impact the prevention of cancer, the quality of life of cancer patients, and the risk of cancer recurrence in the rapidly increasing population of cancer survivors.
Market Analysis and Insights: Global Oncology Nutrition Market
The global Oncology Nutrition market size is projected to reach US$ 2176.2 million by 2026, from US$ 1989.1 million in 2020, at a CAGR of 8.6%% during 2021-2026.
Global Oncology Nutrition Scope and Market Size
Oncology Nutrition market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Nutrition market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Abbott Laboratories
Nestlé
Danone
Fresenius Kabi
B. Braun
...
Head and Neck Cancers
Stomach and Gastrointestinal Cancers
Liver Cancer
Pancreatic Cancer
Esophageal Cancer
Lung Cancer
Breast Cancer
Blood Cancer
Other Cancers
Clinic
Hospitals
North America
Europe
China
Japan
Southeast Asia
India
Nutritional oncology is an increasingly active interdisciplinary field where cancer is investigated as both a systemic and local disease originating with the changes in the genome and progressing through a multi-step process which may be influenced at many points in its natural history by nutritional factors that could impact the prevention of cancer, the quality of life of cancer patients, and the risk of cancer recurrence in the rapidly increasing population of cancer survivors.
Market Analysis and Insights: Global Oncology Nutrition Market
The global Oncology Nutrition market size is projected to reach US$ 2176.2 million by 2026, from US$ 1989.1 million in 2020, at a CAGR of 8.6%% during 2021-2026.
Global Oncology Nutrition Scope and Market Size
Oncology Nutrition market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Nutrition market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Nestlé
Danone
Fresenius Kabi
B. Braun
...
Market segment by Type, the product can be split into
Head and Neck Cancers
Stomach and Gastrointestinal Cancers
Liver Cancer
Pancreatic Cancer
Esophageal Cancer
Lung Cancer
Breast Cancer
Blood Cancer
Other Cancers
Market segment by Application, split into
Clinic
Hospitals
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
